• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

褪黑素能否成为治疗新冠患者的潜在“万灵药”?

Can Melatonin Be a Potential "Silver Bullet" in Treating COVID-19 Patients?

作者信息

Cardinali Daniel P, Brown Gregory M, Pandi-Perumal Seithikurippu R

机构信息

Faculty of Medical Sciences, Pontificia Universidad Católica Argentina, Buenos Aires 1007, Argentina.

Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada.

出版信息

Diseases. 2020 Nov 26;8(4):44. doi: 10.3390/diseases8040044.

DOI:10.3390/diseases8040044
PMID:33256258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7709121/
Abstract

The therapeutic potential of melatonin as a chronobiotic cytoprotective agent to counteract the consequences of COVID-19 infections has been advocated. Because of its wide-ranging effects as an antioxidant, anti-inflammatory, and immunomodulatory compound, melatonin could be unique in impairing the consequences of SARS-CoV-2 infection. Moreover, indirect evidence points out to a possible antiviral action of melatonin by interfering with SARS-CoV-2/angiotensin-converting enzyme 2 association. Melatonin is also an effective chronobiotic agent to reverse the circadian disruption of social isolation and to control delirium in severely affected patients. As a cytoprotector, melatonin serves to combat several comorbidities such as diabetes, metabolic syndrome, and ischemic and non-ischemic cardiovascular diseases, which aggravate COVID-19 disease. In view of evidence on the occurrence of neurological sequels in COVID-19-infected patients, another putative application of melatonin emerges based on its neuroprotective properties. Since melatonin is an effective means to control cognitive decay in minimal cognitive impairment, its therapeutic significance for the neurological sequels of SARS-CoV-2 infection should be considered. Finally, yet importantly, exogenous melatonin can be an adjuvant capable of augmenting the efficacy of anti-SARS-CoV-2 vaccines. We discuss in this review the experimental evidence suggesting that melatonin is a potential "silver bullet" in the COVID 19 pandemic.

摘要

褪黑素作为一种时间生物学细胞保护剂来对抗新冠病毒感染后果的治疗潜力已得到提倡。由于褪黑素作为一种抗氧化、抗炎和免疫调节化合物具有广泛的作用,它在减轻新冠病毒感染后果方面可能具有独特性。此外,间接证据表明褪黑素可能通过干扰新冠病毒与血管紧张素转换酶2的结合而具有抗病毒作用。褪黑素也是一种有效的时间生物学剂,可逆转社交隔离导致的昼夜节律紊乱,并控制重症患者的谵妄。作为一种细胞保护剂,褪黑素有助于对抗几种合并症,如糖尿病、代谢综合征以及缺血性和非缺血性心血管疾病,这些疾病会加重新冠病情。鉴于有证据表明新冠病毒感染患者会出现神经后遗症,基于褪黑素的神经保护特性,它又有了另一种假定的应用。由于褪黑素是控制轻度认知障碍中认知衰退的有效手段,应考虑其对新冠病毒感染神经后遗症的治疗意义。最后,同样重要的是,外源性褪黑素可以作为一种佐剂,增强抗新冠病毒疫苗的效力。我们在本综述中讨论了实验证据,表明褪黑素是新冠疫情中的一种潜在“万灵药”。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624a/7709121/35bf6d1b2077/diseases-08-00044-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624a/7709121/61ce3aba22fc/diseases-08-00044-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624a/7709121/35bf6d1b2077/diseases-08-00044-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624a/7709121/61ce3aba22fc/diseases-08-00044-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624a/7709121/35bf6d1b2077/diseases-08-00044-g002.jpg

相似文献

1
Can Melatonin Be a Potential "Silver Bullet" in Treating COVID-19 Patients?褪黑素能否成为治疗新冠患者的潜在“万灵药”?
Diseases. 2020 Nov 26;8(4):44. doi: 10.3390/diseases8040044.
2
Possible Application of Melatonin in Long COVID.褪黑素在长新冠中的可能应用。
Biomolecules. 2022 Nov 7;12(11):1646. doi: 10.3390/biom12111646.
3
Elderly as a High-risk Group during COVID-19 Pandemic: Effect of Circadian Misalignment, Sleep Dysregulation and Melatonin Administration.老年人作为新冠疫情期间的高危人群:昼夜节律失调、睡眠调节障碍及褪黑素给药的影响
Sleep Vigil. 2020;4(2):81-87. doi: 10.1007/s41782-020-00111-7. Epub 2020 Sep 26.
4
Melatonin and healthy aging.褪黑素与健康老龄化。
Vitam Horm. 2021;115:67-88. doi: 10.1016/bs.vh.2020.12.004. Epub 2021 Feb 5.
5
Protective Effect of Melatonin Administration against SARS-CoV-2 Infection: A Systematic Review.褪黑素给药对新型冠状病毒感染的保护作用:一项系统评价
Curr Issues Mol Biol. 2021 Dec 22;44(1):31-45. doi: 10.3390/cimb44010003.
6
Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.褪黑素可能是一种辅助剂,可改善患有肥胖症和糖尿病且同时感染新冠病毒的个体的临床结局。
Eur J Pharmacol. 2020 Sep 5;882:173329. doi: 10.1016/j.ejphar.2020.173329. Epub 2020 Jun 30.
7
Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection.褪黑素:强调其在治疗 SARS-CoV-2 感染方面的潜在用途。
Cell Mol Life Sci. 2022 Feb 20;79(3):143. doi: 10.1007/s00018-021-04102-3.
8
A comprehensive review on modulation of SIRT1 signaling pathways in the immune system of COVID-19 patients by phytotherapeutic melatonin and epigallocatechin-3-gallate.关于褪黑素和表没食子儿茶素没食子酸酯通过调控 COVID-19 患者免疫系统中的 SIRT1 信号通路的综合综述。
J Food Biochem. 2022 Dec;46(12):e14259. doi: 10.1111/jfbc.14259. Epub 2022 Jun 3.
9
Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).血管紧张素转化酶 2(ACE2)、严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)与 2019 冠状病毒病(COVID-19)的病理生理学。
J Pathol. 2020 Jul;251(3):228-248. doi: 10.1002/path.5471. Epub 2020 Jun 10.
10
Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels.褪黑素药物可抑制 SARS-CoV-2 进入大脑和病毒引起的大脑小血管损伤。
Cell Mol Life Sci. 2022 Jun 13;79(7):361. doi: 10.1007/s00018-022-04390-3.

引用本文的文献

1
Widespread pain syndrome in long COVID-19: melatonin as an adjuvant treatment.长新冠中的广泛性疼痛综合征:褪黑素作为辅助治疗手段
Front Pain Res (Lausanne). 2025 Jun 4;6:1609095. doi: 10.3389/fpain.2025.1609095. eCollection 2025.
2
Phytohormones and emerging plant growth regulators in tailoring plant immunity against viral infections.植物激素和新兴植物生长调节剂在塑造植物抗病毒感染免疫中的作用
Physiol Plant. 2025 Mar-Apr;177(2):e70171. doi: 10.1111/ppl.70171.
3
Circadian re-set repairs long-COVID in a prodromal Parkinson's parallel: a case series.

本文引用的文献

1
Cognitive deficits in people who have recovered from COVID-19.新冠康复者的认知缺陷。
EClinicalMedicine. 2021 Sep;39:101044. doi: 10.1016/j.eclinm.2021.101044. Epub 2021 Jul 23.
2
A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19.一种网络医学方法,用于研究和基于人群的验证 COVID-19 的疾病表现和药物再利用。
PLoS Biol. 2020 Nov 6;18(11):e3000970. doi: 10.1371/journal.pbio.3000970. eCollection 2020 Nov.
3
Elderly as a High-risk Group during COVID-19 Pandemic: Effect of Circadian Misalignment, Sleep Dysregulation and Melatonin Administration.
昼夜节律重置修复长新冠与前驱帕金森平行:一项病例系列研究。
J Med Case Rep. 2024 Oct 23;18(1):496. doi: 10.1186/s13256-024-04812-9.
4
Redox Homeostasis Alteration Is Restored through Melatonin Treatment in COVID-19 Patients: A Preliminary Study.褪黑素治疗可恢复新冠患者的氧化还原稳态改变:一项初步研究
Int J Mol Sci. 2024 Apr 21;25(8):4543. doi: 10.3390/ijms25084543.
5
Vitamin D Supplementation in Neonatal and Infant MIS-C Following COVID-19 Infection.COVID-19 感染后新生儿和婴儿 MIS-C 的维生素 D 补充。
Int J Mol Sci. 2024 Mar 27;25(7):3712. doi: 10.3390/ijms25073712.
6
Comprehensive review of melatonin as a promising nutritional and nutraceutical supplement.褪黑素作为一种有前景的营养及营养保健品的综合综述。
Heliyon. 2024 Jan 8;10(2):e24266. doi: 10.1016/j.heliyon.2024.e24266. eCollection 2024 Jan 30.
7
Study on the correlation between lifestyle and negative conversion time in patients diagnosed with coronavirus disease (COVID-19): a retrospective cohort study.研究冠状病毒病(COVID-19)患者生活方式与阴性转化时间的相关性:回顾性队列研究。
BMC Public Health. 2023 Dec 4;23(1):2410. doi: 10.1186/s12889-023-17163-9.
8
Melatonin and Cytokines Modulate Daily Instrumental Activities of Elderly People with SARS-CoV-2 Infection.褪黑素和细胞因子调节 SARS-CoV-2 感染老年人的日常工具性活动。
Int J Mol Sci. 2023 May 12;24(10):8647. doi: 10.3390/ijms24108647.
9
Melatonin as a Possible Natural Anti-Viral Compound in Plant Biocontrol.褪黑素作为植物生物防治中一种可能的天然抗病毒化合物。
Plants (Basel). 2023 Feb 9;12(4):781. doi: 10.3390/plants12040781.
10
Possible Application of Melatonin in Long COVID.褪黑素在长新冠中的可能应用。
Biomolecules. 2022 Nov 7;12(11):1646. doi: 10.3390/biom12111646.
老年人作为新冠疫情期间的高危人群:昼夜节律失调、睡眠调节障碍及褪黑素给药的影响
Sleep Vigil. 2020;4(2):81-87. doi: 10.1007/s41782-020-00111-7. Epub 2020 Sep 26.
4
Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients.CSF 中的抗 SARS-CoV-2 抗体、血脑屏障功能障碍与神经结局:8 例昏迷患者的研究。
Neurol Neuroimmunol Neuroinflamm. 2020 Sep 25;7(6). doi: 10.1212/NXI.0000000000000893. Print 2020 Nov.
5
COVID-19: Rational discovery of the therapeutic potential of Melatonin as a SARS-CoV-2 main Protease Inhibitor.COVID-19:褪黑素作为 SARS-CoV-2 主要蛋白酶抑制剂的治疗潜力的合理发现。
Int J Med Sci. 2020 Jul 30;17(14):2133-2146. doi: 10.7150/ijms.48053. eCollection 2020.
6
Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines.外源性褪黑素作为抗SARS-CoV-2疫苗的潜在佐剂。
J Neuroimmune Pharmacol. 2020 Dec;15(4):572-573. doi: 10.1007/s11481-020-09956-1. Epub 2020 Sep 10.
7
Melatonin as a putative protection against myocardial injury in COVID-19 infection.褪黑素作为一种可能预防新型冠状病毒肺炎感染所致心肌损伤的物质。
Expert Rev Clin Pharmacol. 2020 Sep;13(9):921-924. doi: 10.1080/17512433.2020.1814141. Epub 2020 Sep 7.
8
Structural and physico-chemical evaluation of melatonin and its solution-state excited properties, with emphasis on its binding with novel coronavirus proteins.褪黑素的结构与物理化学评估及其溶液态激发特性,重点关注其与新型冠状病毒蛋白的结合。
J Mol Liq. 2020 Nov 15;318:114082. doi: 10.1016/j.molliq.2020.114082. Epub 2020 Aug 23.
9
Clinical Trials for Use of Melatonin to Fight against COVID-19 Are Urgently Needed.急需开展 melatonin 抗击 COVID-19 的临床试验。
Nutrients. 2020 Aug 24;12(9):2561. doi: 10.3390/nu12092561.
10
Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?新型冠状病毒病 2019(COVID-19)及其神经侵袭能力:褪黑素是否该登场了?
Cell Mol Neurobiol. 2022 Apr;42(3):489-500. doi: 10.1007/s10571-020-00938-8. Epub 2020 Aug 9.